NAV.V Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 17, 2025
Report Source: 2025 2nd Quarter Report
Navco Pharmaceuticals Inc. Stock Analysis NAV.V
Navco Pharmaceuticals, Inc. engages in the manufacture and research of nano-technology products and materials. The firm is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. The company manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The firm's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. The company offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. The company also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
Read More Navco Pharmaceuticals Inc (NAV.V) Chart
Key Statistics of Navco Pharmaceuticals Inc (NAV.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.01Volume
16.41KP/E Ratio (TTM)
-52 Week Range
Market Cap
278.14KAvg. Volume
10.17KDividend Yield
-Financial Metrics & Statements of Navco Pharmaceuticals Inc (NAV.V)
FAQ's for Navco Pharmaceuticals Inc (NAV.V)
- According to Musaffa’s Shariah screening methodology, Navco Pharmaceuticals Inc (NAV.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.